Efficacy and safety of single-session endscopic ultrasonograpy guided fine needle aspiration biopsy and endscopic retrograde cholangiopancreatography for pathological diagnosis of pancreatic mass lesion.

Efficacy and safety of single-session endscopic ultrasonograpy guided fine needle aspiration biopsy and endscopic retrograde cholangiopancreatography for pathological diagnosis of pancreatic mass lesion. - Efficacy and safety of single-session EUS-FNAB and ERCP for pathological diagnosis of pancreatic mass lesion.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004119

Enrollment

100

Registered

2010-08-31

Start date

2009-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic mass lesion

Interventions

Single-session EUS-FNAB and ERCP is performed for sampling of pathological material to the patients with pancreatic mass lesion.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The study is designed to enroll the patients with suspicious pancreatic mass lesion on CT or US.

Exclusion criteria

Exclusion criteria: The exclusion criteria are as follows: Karnofsky Performance Status <50%, active infection, the patient with inaccessible papilla Vater due to altered anatomy, Bleeding tendency(platelets<50000/mm3, prothrombin time<50%), severe complication such as liver cirrhosis and heart disease, active concomitant malignancy, and the patient inappropriate for entry onto this study under the judgment of the investigator. Written informed consent is required from all patients.

Design outcomes

Primary

Measure	Time frame
Accomplishment rate of procedure within 70 minutes	—

Secondary

Measure	Time frame
Accomplishment rate of procedure Total time of procedure Complication rate	—

Countries

Japan

Contacts

Public ContactHirofumi Kawamoto

Okayama University Hospital Departments of Gastroenterology

h-kawamo@md.okayama-u.ac.jp086-223-7151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026